Premium Nahrungsergänzungsmittel | artgerecht

Transdermal Hormone Therapy – How It Works

Transdermal hormone therapy is a treatment in which hormones are delivered into the body through the skin. It is commonly used to relieve menopausal symptoms.

Regular tips about health Regular tips about health

Things worth knowing about "Transdermal Hormone Therapy"

Transdermal hormone therapy is a treatment in which hormones are delivered into the body through the skin. It is commonly used to relieve menopausal symptoms.

What is Transdermal Hormone Therapy?

Transdermal hormone therapy (also known as transdermal hormone replacement therapy or transdermal HRT) is a method of administering hormones such as estrogen or progesterone directly through the skin. Unlike oral hormone tablets, this route of delivery bypasses the so-called hepatic first-pass effect, meaning the hormones enter the bloodstream directly without first passing through the liver. Common application forms include patches, gels, sprays, and creams.

Indications

Transdermal hormone therapy is primarily used in the following situations:

Menopausal symptoms (climacteric): hot flushes, night sweats, sleep disturbances, mood changes, and vaginal dryness
Osteoporosis prevention: protecting bone density from estrogen-deficiency-related bone loss
Premature menopause or surgically induced menopause (e.g., after removal of the ovaries)
Hypogonadism: hormone deficiency in women and men
Gender-affirming hormone therapy: as part of a gender transition treatment plan

Mechanism of Action

When applied transdermally, hormone molecules penetrate the outer layer of the skin (the stratum corneum) and are absorbed through the capillaries in the dermis into the bloodstream. This results in steady, consistent hormone levels in the blood, avoiding the peaks and fluctuations that are typical with oral administration. Estradiol, the biologically active form of estrogen, can thus be delivered directly and effectively without prior hepatic metabolism.

Advantages Over Oral Hormone Therapy

Bypasses the hepatic first-pass effect: reduced liver burden
Lower risk of thromboembolic events (blood clots) compared to oral estrogens
More stable hormone levels throughout the day
Better tolerability for patients with gastrointestinal issues
Convenient application and flexible dosing (e.g., adjustable gel amounts or patch sizes)

Dosage and Application

The exact dosage depends on the product used, the indication, and the individual needs of the patient, and should always be determined by a qualified healthcare professional. Typical application guidelines include:

Patches: usually applied twice a week or once a week to clean, dry skin (e.g., abdomen or thigh)
Gel: applied daily to a larger skin area (e.g., arms, shoulders); should be allowed to dry without rubbing
Spray: applied to the forearm; dosage measured in pump actuations

Side Effects and Risks

As with any hormone therapy, side effects may occur with transdermal application. Common side effects include:

Skin irritation or redness at the application site (particularly with patches)
Breast tenderness or breast tension
Headaches and nausea (less frequent than with oral therapy)
Mood changes or fluid retention

More serious risks that should be discussed with a healthcare provider include:

Increased risk of breast cancer with long-term combined estrogen-progestogen therapy
Possible increased risk of endometrial cancer with estrogen-only therapy (in women with an intact uterus)
Lower cardiovascular risk compared to oral therapy, but still a relevant consideration

Contraindications

Transdermal hormone therapy is not suitable for individuals with:

Known or suspected hormone-dependent malignancies (e.g., breast cancer, endometrial cancer)
Unexplained genital tract bleeding
Acute thromboembolic disorders
Severe liver disease
Known hypersensitivity to the active ingredients or excipients

Diagnosis and Medical Supervision

Before starting transdermal hormone therapy, a comprehensive medical assessment is typically performed, including:

Review of medical history and current symptoms
Blood tests to measure hormone levels (e.g., FSH, LH, estradiol)
Gynecological examination and, where appropriate, mammography
Individual risk-benefit assessment for each patient

Regular follow-up appointments (at least once a year) are recommended during treatment to monitor therapeutic progress and identify potential risks at an early stage.

References

Baber R. J. et al. - 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric, 2016;19(2):109–150.
The NAMS 2022 Hormone Therapy Position Statement Advisory Panel - The 2022 hormone therapy position statement of The Menopause Society. Menopause, 2022;29(7):767–794.
European Medicines Agency (EMA): Scientific guidelines on transdermal hormone therapy products. Available at: www.ema.europa.eu

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.